A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis

[1]  M. J. Walsh,et al.  Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. , 1998, The Journal of clinical investigation.

[2]  M. Daly,et al.  Genomewide scan of multiple sclerosis in Finnish multiplex families. , 1997, American journal of human genetics.

[3]  M. Carrington,et al.  Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients. , 1997 .

[4]  D. Douer,et al.  An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. , 1997, Blood.

[5]  B. Becher,et al.  Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis , 1997, Journal of Neuroimmunology.

[6]  J. Newcombe,et al.  The Expression of Tissue‐type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis: Comparison of Stages in Lesion Evolution , 1996, Journal of neuropathology and experimental neurology.

[7]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[8]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[9]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[10]  D. Hinds,et al.  A full genome search in multiple sclerosis , 1996, Nature Genetics.

[11]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[12]  D. Clayton,et al.  Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. , 1996, Brain : a journal of neurology.

[13]  R. Sobel,et al.  Matrix Metalloproteinases in the Normal Human Central Nervous System, Microglial Nodules, and Multiple Sclerosis Lesions , 1996, Journal of neuropathology and experimental neurology.

[14]  R. Kucherlapati,et al.  Neuronal abnormalities in microtubule-associated protein 1B mutant mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Goetzl,et al.  Matrix metalloproteinases in immunity. , 1996, Journal of immunology.

[16]  R. Hughes,et al.  Neurofibromatosis 1 and multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[17]  S. C. Jenkins,et al.  Chromosome–specific microsatellite sets for fluorescence–based, semi–automated genome mapping , 1994, Nature Genetics.

[18]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[19]  A. Sadovnick,et al.  Multiple sclerosis: updated risks for relatives. , 1988, American journal of medical genetics.

[20]  R. Brady,et al.  Myelin‐associated glycoprotein in multiple sclerosis lesions: A quantitative and qualitative analysis , 1987, Annals of neurology.

[21]  J. Ott.  Analysis of Human Genetic Linkage , 1985 .

[22]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[23]  Erland Nelson.  The Epidemiology of Multiple Sclerosis , 1969 .